Sense Diagnostics
Sense Neuro Diagnostics develops non-invasive tech for rapid stroke detection and brain injury monitoring.
Founded
2014Sense Neuro Diagnostics develops non-invasive tech for rapid stroke detection and brain injury monitoring.
Sense Neuro Diagnostics develops non-invasive technology for rapid detection of stroke and traumatic brain injury, as well as continuous monitoring of brain injuries in hospital settings. Their mission is to provide timely and accurate diagnostic tools that can be utilized in both field environments and medical facilities to improve patient outcomes. The company focuses on creating solutions that enable healthcare providers to quickly identify and treat neurological conditions, ultimately aiming to save lives and reduce long-term disabilities.
Sense Neuro Diagnostics has made significant strides in the medical technology field, contributing to advancements in neurodiagnostic tools. Their innovative approach has garnered attention and support from the medical community, enhancing the capabilities of emergency responders and hospital staff in managing critical brain injuries. The company's impact is reflected in its commitment to improving diagnostic accuracy and speed, which is crucial in the treatment of strokes and traumatic brain injuries.
Companies similar to Sense Diagnostics include StrokeDx, Activas Diagnostics, CranioSense and Cerebrotech Medical Systems.
Sense Diagnostics was founded in 2014.
Sense Diagnostics' headquarters is located in Cincinnati, OH, US.
Sense Diagnostics' most recent funding round was for $250k (USD) in March 2023.
As of Mar 20, 2023, Sense Diagnostics has disclosed funding of $14.2M (USD). Undisclosed round amounts are excluded.
Sense Diagnostics has 15 employees as of Feb 5, 2024.
Cerebrotech Medical Systems
